(TOP (S (S (NP-SBJ (NP (NNS Scientists))
                   (PP (IN from)
                       (NP (NP (DT the)
                               (NNP UK))
                           (, ,)
                           (NP (NNP France))
                           (CC and)
                           (NP (NNP Canada)))))
           (VP (VBD reported)
               (PP-LOC (IN in)
                       (NP (NP (NP (DT the)
                                   (JJ American)
                                   (NN journal))
                               ('' ")
                               (NP-TTL (NNP Science)))
                           ('' ")
                           (, ,)
                           (VP (VBN published)
                               (NP (-NONE- *))
                               (PP-TMP (IN on)
                                       (NP (DT the)
                                           (JJ second))))))
               (, ,)
               (SBAR (IN that)
                     (S (NP-SBJ (PRP they))
                        (VP (VP (VBD selected)
                                (NP (QP (RB approximately)
                                        (CD 650))
                                    (ADJP (JJ middle)
                                          (HYPH -)
                                          (JJ aged))
                                    (NNS people)))
                            (, ,)
                            (CC and)
                            (VP (VBD tracked)
                                (CC and)
                                (VBD studied)
                                (NP (PRP them))
                                (PP-TMP (IN for)
                                        (NP (CD nine)
                                            (NNS years)))))))))
        (: ;)
        (S (NP-SBJ (DT these)
                   (NNS people))
           (VP (VP (VBD were)
                   (ADVP (RB generally))
                   (ADJP-PRD (JJ healthy)))
               (CC and)
               (VP (VBD had)
                   (NP (NP (DT no)
                           (NN history))
                       (PP (IN of)
                           (NP (NN diabetes)))))))
        (. .)))

(TOP (S (NP-SBJ (DT The)
                (NN research)
                (NNS results))
        (VP (VBD showed)
            (SBAR (IN that)
                  (S (SBAR-TMP (IN after)
                               (S (NP-SBJ (DT the)
                                          (NNP G6PC2)
                                          (NN gene))
                                  (VP (VBZ becomes)
                                      (ADJP-PRD (JJ modified)))))
                     (, ,)
                     (NP-SBJ (PRP it))
                     (VP (MD can)
                         (VP (VP (VB disturb)
                                 (NP (NP (DT the)
                                         (NNS activities))
                                     (PP (IN of)
                                         (NP (NP (NN glucokinase))
                                             (, ,)
                                             (SBAR (WHNP-1 (WDT which))
                                                   (S (NP-SBJ-2 (-NONE- *T*-1))
                                                      (VP (VBZ is)
                                                          (ADJP-PRD (JJ responsible)
                                                                    (PP (IN for)
                                                                        (S-NOM (NP-SBJ (-NONE- *PRO*-2))
                                                                               (VP (VBG regulating)
                                                                                   (CC and)
                                                                                   (VBG controlling)
                                                                                   (NP (NP (DT the)
                                                                                           (NN body)
                                                                                           (POS 's))
                                                                                       (NML (NN blood)
                                                                                            (NN sugar))
                                                                                       (NN level)))))))))))))
                             (CC and)
                             (, ,)
                             (PP (IN as)
                                 (NP (DT a)
                                     (NN result)))
                             (, ,)
                             (VP (VB cause)
                                 (S (NP-SBJ (DT the)
                                            (NML (NN blood)
                                                 (NN sugar))
                                            (NN level))
                                    (VP (TO to)
                                        (VP (VP (VB go)
                                                (`` ")
                                                (PP-CLR (IN out)
                                                        (PP (IN of)
                                                            (NP (NN control))))
                                                ('' "))
                                            (CC and)
                                            (VP (VB increase)
                                                (PP-CLR (IN to)
                                                        (NP (DT a)
                                                            (`` ")
                                                            (JJ dangerous)
                                                            (NN level)))))))))))))
        (. .)
        ('' ")))

(TOP (S (PP (IN Under)
            (NP (JJ normal)
                (NNS circumstances)))
        (, ,)
        (NP-SBJ-1 (NN glucokinase))
        (VP (VBZ acts)
            (PP-CLR (IN as)
                    (NP (DT a)
                        (`` ")
                        (NN monitor)))
            (, ,)
            ('' ")
            (S-ADV (NP-SBJ (-NONE- *PRO*-1))
                   (ADVP-MNR (RB strictly))
                   (VP (VBG monitoring)
                       (CC and)
                       (VBG controlling)
                       (NP (NML (NN blood)
                                (NN sugar))
                           (NNS levels)))))
        (. .)))

(TOP (S (S (NP-SBJ (PRP It))
           (VP (MD can)
               (VP (VB send)
                   (NP (NNS signals))
                   (PP-DTV (IN to)
                           (NP (NP (DT the)
                                   (NN body)
                                   (POS 's))
                               (NN beta)
                               (NNS cells))))))
        (: ;)
        (S (NP-SBJ (DT the)
                   (NN beta)
                   (NNS cells))
           (VP (MD will)
               (ADVP-TMP (RB then))
               (VP (VP (VB secrete)
                       (NP (NN insulin)))
                   (, ,)
                   (CC and)
                   (VP (VB keep)
                       (NP (NP (DT the)
                               (NN body)
                               (POS 's))
                           (NML (NN blood)
                                (NN sugar))
                           (NN level))
                       (PP-LOC (IN within)
                               (NP (DT a)
                                   (JJ normal)
                                   (NN range)))
                       (PP-TMP (IN at)
                               (NP (DT all)
                                   (NNS times)))))))
        (. .)))

(TOP (S (SBAR-TMP (IN Once)
                  (S (NP-SBJ (NN glucokinase))
                     (VP (VBZ becomes)
                         (`` ")
                         (ADJP-PRD (JJ paralyzed)))))
        (, ,)
        ('' ")
        (S (NP-SBJ (NP (DT the)
                       (NN person)
                       (POS 's))
                   (NML (NN blood)
                        (NN sugar))
                   (NN level))
           (VP (MD will)
               (VP (VB increase))))
        (, ,)
        (CC and)
        (S (NP-SBJ (NP (DT the)
                       (NN risk))
                   (PP (IN of)
                       (S-NOM (NP-SBJ (-NONE- *PRO*))
                              (VP (VBG suffering)
                                  (PP-CLR (IN from)
                                          (NP (NP (JJ coronary)
                                                  (NN arteriosclerosis))
                                              (CC and)
                                              (NP (JJ other)
                                                  (NNS diseases))))))))
           (VP (MD will)
               (ADVP (RB also))
               (VP (VB increase))))
        (. .)))

(TOP (S (NP-SBJ (NNS Scientists))
        (VP (VBD said)
            (SBAR (IN that)
                  (S (NP-SBJ (NP (NNS polymorphisms))
                             (PP-LOC (IN within)
                                     (NP (DT the)
                                         (NNP G6PC2)
                                         (NN gene))))
                     (VP (MD can)
                         (ADVP (RB probably))
                         (VP (VB increase)
                             (NP (NML (NN blood)
                                      (NN sugar))
                                 (NN level))
                             (PP-EXT (IN by)
                                     (NP (QP (RB approximately)
                                             (CD 5))
                                         (NN %))))))))
        (. .)))

(TOP (S (NP-SBJ-1 (DT This)
                  (NN percentage))
        (VP (VP (VBZ does)
                (RB not)
                (VP (VB appear)
                    (S (NP-SBJ (-NONE- *-1))
                       (ADJP-PRD (JJ large)))))
            (, ,)
            (CC but)
            (VP (VBZ is)
                (ADJP-PRD (JJ sufficient)
                          (S (NP-SBJ (-NONE- *PRO*-1))
                             (VP (TO to)
                                 (VP (VB threaten)
                                     (NP (NP (DT a)
                                             (NN person)
                                             (POS 's))
                                         (NN health))))))))
        (. .)))

